Top Markets
#1 MON MON +2,760.99%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +52.39%
#4 eCash eCash +39.09%
#5 PinGo PinGo +28.27%
#6 Siren Siren +24.14%
#7 Collector Crypt Collector Crypt +23.46%
#8 Janction Janction +20.22%
#9 SAFEcoin SAFEcoin +19.71%
#10 Cap Cap +14.67%
Coin of the day
MON MON
설정
언어
한국어
통화
USD
테마
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
주식 순위 #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
주가
$0.30780727
시가총액
$94.19M
변동 (1일)
-0.19%
변동 (1년)
-34.73%
국가
FR
거래 Sensorion SA (ALSEN)

카테고리

Healthcare
Sensorion SA (ALSEN)의 EPS
December 2025 기준 EPS TTM: $-0.11
Sensorion SA의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.11입니다. 2023년 말에는 회사의 EPS가 $-0.19였으며, 이는 2022년의 EPS $-0.31와 감소입니다.
Sensorion SA의 EPS 기록 (2011 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.11 14.90%
2024 $-0.10 -49.33%
2023 $-0.19 -39.60%
2022 $-0.31 43.96%
2021 $-0.22 18.28%
2020 $-0.18 -74.95%
2019 $-0.73 -41.24%
2018 $-1.24 -22.81%
2017 $-1.61 40.20%
2016 $-1.15 5.63%
2015 $-1.09 -4.53%
2014 $-1.14 65.40%
2013 $-0.69 73.77%
2012 $-0.40 103.76%
2011 $-0.19 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $4.36 -3,893.12%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.01 -14,904.18%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $42.53 -37,114.80%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 -8,473.19%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $26.66 -23,302.79%
NL